Koshinski Asset Management Inc. bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,885 shares of the company's stock, valued at approximately $226,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of USPH. Nuveen LLC bought a new position in U.S. Physical Therapy in the first quarter valued at about $8,702,000. Bahl & Gaynor Inc. grew its position in U.S. Physical Therapy by 32.6% in the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock valued at $24,964,000 after acquiring an additional 84,878 shares during the last quarter. Copeland Capital Management LLC grew its position in U.S. Physical Therapy by 8.9% in the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock valued at $69,499,000 after acquiring an additional 72,463 shares during the last quarter. Woodline Partners LP grew its position in U.S. Physical Therapy by 228.0% in the first quarter. Woodline Partners LP now owns 82,419 shares of the company's stock valued at $5,964,000 after acquiring an additional 57,293 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in shares of U.S. Physical Therapy by 249.3% during the first quarter. Jane Street Group LLC now owns 49,309 shares of the company's stock valued at $3,568,000 after purchasing an additional 35,191 shares in the last quarter.
Insider Transactions at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 600 shares of the business's stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $81.71, for a total value of $49,026.00. Following the transaction, the director directly owned 1,994 shares of the company's stock, valued at approximately $162,929.74. The trade was a 23.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the completion of the transaction, the chief executive officer directly owned 114,088 shares in the company, valued at approximately $9,529,770.64. This trade represents a 1.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,853 shares of company stock valued at $581,406. 2.00% of the stock is owned by insiders.
U.S. Physical Therapy Price Performance
U.S. Physical Therapy stock opened at $89.60 on Wednesday. The stock's 50 day moving average is $84.98 and its 200 day moving average is $78.28. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market cap of $1.36 billion, a P/E ratio of 39.13, a P/E/G ratio of 4.49 and a beta of 1.48. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. The company had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.
U.S. Physical Therapy Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.0%. U.S. Physical Therapy's payout ratio is 78.60%.
Wall Street Analysts Forecast Growth
USPH has been the topic of several research reports. Weiss Ratings restated a "hold (c)" rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. Wall Street Zen cut U.S. Physical Therapy from a "buy" rating to a "hold" rating in a report on Sunday, September 21st. JPMorgan Chase & Co. initiated coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They set an "overweight" rating and a $110.00 price target on the stock. Barrington Research boosted their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Finally, Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.
Check Out Our Latest Research Report on USPH
About U.S. Physical Therapy
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Stories
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report